|
⚲
|
| Keyboard |
| Ishara Investments LP
✚
|
|
|---|---|
| CRD # | 331869 |
| SEC # | 801-131633 |
| CIK # | 0002111609 |
| AUM | 259.1 M (2026-03-19) |
| Employees | 6 (83% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 818-983-4448 |
| Address | 8929 Exposition Blvd Los Angeles, CA 90034 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002111609 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 13.9 | ||
| Axsome Therapeutics Inc | 6.9 | ||
| Xeris Biopharma Holdings Inc | 5.9 | ||
| BioMarin Pharmaceutical Inc | 4.6 | ||
| Verastem Inc | 4.3 | ||
| Ultragenyx Pharmaceutical Inc | 3.7 | ||
| Arrowhead Research Corp | 3.5 | ||
| Vaxcyte Inc | 3.3 | ||
| Vera Therapeutics Inc | 3.3 | ||
| Desert Gateway Inc | 3.3 | ||
| Helix Acquisition Corp | 3.2 | ||
| Zentalis Pharmaceuticals Inc | 2.9 | ||
| Scholar Rock Holding Corp | 2.8 | ||
| Acadia Pharmaceuticals Inc | 2.7 | ||
| Ardelyx Inc | 2.7 | ||
| Mineralys Therapeutics Inc | 2.2 | ||
| Genmab A/S | 2.2 | ||
| DBV Technologies Sa | 2.1 | ||
| Catalyst Pharmaceutical Partners Inc | 2.0 | ||
| Sionna Therapeutics Inc | 2.0 | ||
| Contineum Therapeutics Inc | 1.9 | ||
| Alnylam Pharmaceuticals Inc | 1.7 | ||
| Ligand Pharmaceuticals Inc | 1.6 | ||
| Edgewise Therapeutics Inc | 1.5 | ||
| Immatics NV | 1.5 | ||
| Lexicon Pharmaceuticals Inc/DE | 1.4 | ||
| Beam Therapeutics Inc | 1.4 | ||
| Oric Pharmaceuticals Inc | 1.3 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Ishara Biotech Fund LP | [2025-03-14] | 8.5 M | 19.9 M |
| Filed 2026-01-20 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 259.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 259.1 |
| By Discretionary | ||
| Discretionary | 3 | 259.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 259.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 239.3 | |
| United States Persons | 19.9 | |
| Total | 3 | 259.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ishara Partners GP LLC | Executive Officer | 1 | 1 | |
| Shaun Mehra | Executive Officer | 1 | 1 | |
| Ishara Investments LP | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002111609] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.0B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900853I0DC6EYQS17 |
| Comparable Firms | State | AUM |
|---|---|---|
|
KWK Management LLC
✚
|
TX | 262.5 M |
|
Empery Asset Management LP
✚
|
NY | 262.5 M |
|
Spruce Point Capital Management LLC
✚
|
NY | 262.2 M |
|
Room40 Capital LLC
✚
|
NY | 261.7 M |
|
Nantucket Multi Managers LLC
✚
|
MI | 260.2 M |
|
Magarian Capital Management LLC
✚
|
TX | 259.7 M |
|
Incline Global Management LLC
✚
|
NY | 259.0 M |
|
Geosphere Capital Management LLC
✚
|
FL | 258.4 M |
|
Pluscios Management LLC
✚
|
IL | 258.1 M |
|
Frontaura Capital LLC
✚
|
IL | 256.6 M |